共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R012393-50mg | 50mg | 5~7个工作日 |
罗乐替尼 CO-1686 (AVL-301) |
99% |
|
|
罗恩 |
R012393-10mg
当天发货 |
10mg | 现货 |
罗乐替尼 CO-1686 (AVL-301) |
99% |
|
|
阿拉丁 | C124905-10mg | 10mg | 现货 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
Moligand™, ≥99% |
|
|
阿拉丁 | C124905-50mg | 50mg | 现货 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
Moligand™, ≥99% |
|
|
阿拉丁 | C124905-5mg | 5mg | 现货 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
Moligand™, ≥99% |
|
|
阿拉丁 | C124905-100mg | 100mg | 现货 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
Moligand™, ≥99% |
|
|
阿拉丁 | C421423-1ml | 1ml | 现货 |
CO-1686 (AVL-301) CO-1686 (AVL-301) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ003AL9-100mg | 100mg | 期货,请咨询 |
N-[3-[[2-[[4-(4-乙酰基-1-哌嗪基)-2... N-[3-[[2-[[4-(4-Acetyl-1-pip... |
98% |
|
|
凯为 | JZ003AL9-250mg | 250mg | 期货,请咨询 |
N-[3-[[2-[[4-(4-乙酰基-1-哌嗪基)-2... N-[3-[[2-[[4-(4-Acetyl-1-pip... |
98% |
|
|
凯为 | JZ003AL9-50mg | 50mg | 期货,请咨询 |
N-[3-[[2-[[4-(4-乙酰基-1-哌嗪基)-2... N-[3-[[2-[[4-(4-Acetyl-1-pip... |
98% |
|
|
毕得 | BD293480-50mg | 50mg | 现货 |
N-(3-((2-((4-(4-乙酰哌嗪-1-基)-2-... N-(3-((2-((4-(4-Acetylpipera... |
98% |
|
|
毕得 | BD293480-100mg | 100mg | 现货 |
N-(3-((2-((4-(4-乙酰哌嗪-1-基)-2-... N-(3-((2-((4-(4-Acetylpipera... |
98% |
|
|
毕得 | BD293480-250mg | 250mg | 现货 |
N-(3-((2-((4-(4-乙酰哌嗪-1-基)-2-... N-(3-((2-((4-(4-Acetylpipera... |
98% |
|
|
毕得 | BD293480-1g | 1g | 现货 |
N-(3-((2-((4-(4-乙酰哌嗪-1-基)-2-... N-(3-((2-((4-(4-Acetylpipera... |
98% |
|
|
百灵威 | JK1684920-5MG | 5MG | 1天 |
罗乐替尼 Rociletinib, 98%, an orally ... |
98% |
|
|
百灵威 | JK1684920-25MG | 25MG | 35天 |
罗乐替尼 Rociletinib, 98%, an orally ... |
98% |
|
|
Matrix | MA132344-1g | 1g | 3-4周 |
N-(3-((2-((4-(4-Acetylpipera... N-(3-((2-((4-(4-Acetylpipera... |
97% | 咨询 | 请联系客服购买! |
Matrix | MA132344-5g | 5g | 3-4周 |
N-(3-((2-((4-(4-Acetylpipera... N-(3-((2-((4-(4-Acetylpipera... |
97% | 咨询 | 请联系客服购买! |
源叶 | S42346-5mg | 5mg | 期货,请咨询 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
≥99% |
|
|
源叶 | S42346-10mg | 10mg | 期货,请咨询 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
≥99% |
|
|
源叶 | S42346-50mg | 50mg | 期货,请咨询 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
≥99% |
|
|
源叶 | S42346-100mg | 100mg | 期货,请咨询 |
CO-1686(AVL-301),EGFR抑制剂 CO-1686 (AVL-301) |
≥99% |
|
|
源叶 | T88284-1ml | 1ml | 期货,请咨询 |
CO-1686 (AVL-301) CO-1686 (AVL-301) |
10mM in DMSO |
|
|
Target Mol | T2369-5mg | 5mg | 现货 |
化合物 Rociletinib Rociletini |
99.25% |
|
|
Target Mol | T2369-10mg | 10mg | 现货 |
化合物 Rociletinib Rociletini |
99.25% |
|
|
Target Mol | T2369-50mg | 50mg | 现货 |
化合物 Rociletinib Rociletini |
99.25% |
|
|
Target Mol | T2369-100mg | 100mg | 现货 |
化合物 Rociletinib Rociletini |
99.25% |
|
|
Target Mol | T2369-1mL | 1mL | 现货 |
化合物 Rociletinib Rociletini |
99.25% |
|
|
Combi | QV-6044-100mg | 100mg | 请咨询 |
Co-1686 Co-1686 |
95% | 咨询 | 请联系客服购买! |
Combi | QV-6044-250mg | 250mg | 请咨询 |
Co-1686 Co-1686 |
95% | 咨询 | 请联系客服购买! |
Combi | QV-6044-1g | 1g | 请咨询 |
Co-1686 Co-1686 |
95% | 咨询 | 请联系客服购买! |
Am | A254041-10mg | 10mg | 现货 |
Rociletinib Rociletini |
98% |
|
|
Am | A254041-100mg | 100mg | 现货 |
Rociletinib Rociletini |
98% |
|
|
Am | A254041-5mg | 5mg | 现货 |
Rociletinib Rociletini |
98% |
|
|
Am | A254041-50mg | 50mg | 现货 |
Rociletinib Rociletini |
98% |
|
|
MCE | HY-15729-100mg | 100mg | 现货 |
Rociletinib Rociletini |
99.79% |
|
|
MCE | HY-15729-50mg | 50mg | 现货 |
Rociletinib Rociletini |
99.79% |
|
|
MCE | HY-15729-10mg | 10mg | 现货 |
Rociletinib Rociletini |
99.79% |
|
|
MCE | HY-15729-10mM*1mL | 10mM*1mL | 现货 |
Rociletinib Rociletini |
99.79% |
|
|
MCE | HY-15729-5mg | 5mg | 现货 |
Rociletinib Rociletini |
99.79% |
|
|